Vincent Martin is a Professor of Biology at Concordia University where he held the Canada Research Chair in Microbial Genomics and Engineering (2004-14) and currently holds the Concordia University Research Chair in Microbial Engineering and Synthetic Biology. In 2012 he established and is now Co-Director of the Concordia Centre for Applied Synthetic Biology, Canada's only research centre focused on synthetic biology, also home to The Genome Foundry, a unique CFI-funded technology platform that aspires to accelerate the design-build-test cycle of biological engineering.
Dr. Martin is a founder of the biotech company Amyris Inc, which was based on his postdoctoral research at UC Berkeley. He is now leveraging his entrepreneurship experience for the development of a Life Science's hub as part of Concordia's District 3 Centre for Innovation and Entrepreneurship. Prof Martin earned his BSc from McGill University, a MSc from The University of Guelph and PhD from the University of British Columbia. In 2014 he was elected to the Royal Society of Canada, College of New Scholars, Artists and Scientists.